Abstract
Purpose To determine the nature and prevalence of workers’ concerns regarding workplaces reopening during the pandemic. To identify characteristics of workers and industries where particular concerns are more common.
Methods Prospective cohort study of 1063 employed Australian adults, enrolled at the start of the pandemic. Data on attitudes to workplaces reopening were collected 1 July – 30 September 2020. The frequency of concerns describes infection risk and changes to work and impact on home life. Regression models examined associations between demographic and industry factors with reopening concerns.
Results More than four in five (82.4%) of workers reported concerns about workplace infection risk. Just over half (53.4%) reported concerns about impacts to work and home life. Concerns were more prevalent for workers reporting psychological distress, financial stress, and among those exclusively working from home. Concerns regarding infection risk were common for workers in health care (IRR=1.16, 95% CI=[1.01, 1.33]), retail (IRR=1.31, 95% CI=[1.06, 1.61]), and accommodation/food service industries (IRR=1.25, 95% CI=[1.01, 1.55]). Concerns regarding changes to work and home life were more common for female workers (IRR=1.24, 95% CI=[1.07, 1.43]), and partners/spouses with dependent children (IRR=1.44, 95% CI=[1.16, 1.79]).
Conclusion Concerns of COVID-19 infection in the workplace are common. Many workers are also concerned about changes to their work and home life. The prevalence of concerns is related to the nature of work and responsibilities at home. Actions that reduce risk of workplace transmission, coupled with effective communication of infection controls, may alleviate worker concerns whilst recognising workers’ family and social circumstances.
Competing Interest Statement
Funding was provided by Monash University and the icare Foundation. The views expressed are those of the authors and may not reflect the views of study funders.
Clinical Trial
ACTRN12620000857909
Funding Statement
Funding was provided by Monash University and the icare Foundation. The views expressed are those of the authors and may not reflect the views of study funders. Professor Alex Collie is supported by an ARC Future Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval to conduct the study was provided by Monash University Human Research Ethics Committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data are held at Monash University, Insurance Work and Health Group, School of Public Health and Preventive Medicine. Procedures to access data from this study are available through contacting the lead author. Proposals for collaborative analyses will be considered by the study's investigator team.
